Skip to content
2000
Volume 32, Issue 35
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background

The role of LNX1 antisense RNA 2 (LNX1-AS2) in lung adenocarcinoma (LUAD) remains unclear.

Objective

This study aimed to investigate the association between LNX1-AS2 and LUAD by employing bioinformatics analysis and experimental validation.

Methods

Statistical analysis and database interrogation were utilized to assess correlations among LNX1-AS2 expression, clinical characteristics of LUAD patients, prognostic factors, regulatory networks, and immune infiltration. LNX1-AS2 expression in LUAD cell lines was quantified using quantitative real-time polymerase chain reaction (qRT-PCR).

Results

The study found significantly elevated levels of LNX1-AS2 expression in patients with LUAD. Furthermore, elevated LNX1-AS2 expression in LUAD patients did not significantly correlate with gender ( = 0.041) or race ( = 0.049). Importantly, high LNX1-AS2 expression levels were associated with poorer overall survival (OS, = 0.042) and disease-specific survival (DSS, = 0.040) in LUAD patients. Additionally, high LNX1-AS2 expression ( = 0.015) was independently correlated with OS in LUAD patients. The phenotype characterized by high LNX1-AS2 expression was also found to be enriched for asthma, allograft rejection, drug metabolism cytochrome P450, metabolism of xenobiotics by cytochrome P450, olfactory transduction, renin-angiotensin system, retinol metabolism, pentose and glucuronate interconversions, and porphyrin and chlorophyll metabolism. A significant correlation was identified between the expression levels of LNX1-AS2 and immune infiltration in the context of LUAD. Elevated expression of LNX1-AS2 was notably detected in LUAD cell lines as opposed to Beas-2B.

Conclusion

A noteworthy relationship was established among increased LNX1-AS2 expression in LUAD patients, unfavorable prognosis, and heightened immune infiltration. These findings suggest that the LNX1-AS2 gene could serve as a valuable prognostic indicator for LUAD and a potential predictor of response to immunotherapy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673321029241015153958
2024-10-31
2025-10-31

  • From This Site

    /content/journals/cmc/10.2174/0109298673321029241015153958
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Vergara-FernandezO. Trejo-AvilaM. Salgado-NesmeN. Sarcopenia in patients with colorectal cancer: A comprehensive review.World J. Clin. Cases2020871188120210.12998/wjcc.v8.i7.118832337193
     [Google Scholar]
  2. LiangW. LuY. PanX. ZengY. ZhengW. LiY. NieY. LiD. WangD. Decreased expression of a novel lncRNA FAM181A-AS1 is associated with poor prognosis and immune infiltration in lung adenocarcinoma.Pharm. Genomics Pers. Med.20221598599810.2147/PGPM.S38490136482943
     [Google Scholar]
  3. KongF. YangX. LuZ. LiuZ. YangY. WangZ. A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis.PeerJ202311e1616710.7717/peerj.1616738047034
     [Google Scholar]
  4. XiaoJ. ChenX. LuX. XieM. HeB. HeS. YouS. ChenQ. Progesterone/Org inhibits lung adenocarcinoma cell growth via membrane progesterone receptor alpha.Thorac. Cancer20201182209222310.1111/1759‑7714.1352832529777
     [Google Scholar]
  5. ChenS. HuangC. JinE. Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression.J. Cardiothorac. Surg.20241918810.1186/s13019‑024‑02507‑238347625
     [Google Scholar]
  6. BaraibarI. RomanM. Rodríguez-RemírezM. LópezI. VilaltaA. GuruceagaE. EcayM. CollantesM. LozanoT. AlignaniD. PuyaltoA. OliverA. Ortiz-EspinosaS. MorenoH. TorregrosaM. RolfoC. CaglevicC. García-RosD. Villalba-EsparzaM. De AndreaC. VicentS. PíoR. LasarteJ.J. CalvoA. AjonaD. Gil-BazoI. Id1 and PD-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-L1 expression and tumor infiltrating CD8+ T Cells.Cancers20201211316910.3390/cancers1211316933126649
     [Google Scholar]
  7. LiuH.Y. LuS.R. GuoZ.H. ZhangZ.S. YeX. DuQ. LiH. WuQ. YuB. ZhaiQ. LiuJ.L. lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer.JIM.AFMR20206815259
     [Google Scholar]
  8. ZhangR. MaL. LiW. ZhouS. XuS. Diagnostic value of multiple tumor-associated autoantibodies in lung cancer.OncoTargets Ther.20191245746910.2147/OTT.S18773430666125
     [Google Scholar]
  9. MattickJ.S. MakuninI.V. Non-coding RNA.Hum. Mol. Genet.200615Spec No 1Suppl. 1R17R2910.1093/hmg/ddl04616651366
     [Google Scholar]
  10. WangX. LiL. ZhaoK. LinQ. LiH. XueX. GeW. HeH. LiuD. XieH. WuQ. HuY. A novel LncRNA HITT forms a regulatory loop with HIF-1α to modulate angiogenesis and tumor growth.Cell Death Differ.20202741431144610.1038/s41418‑019‑0449‑831700144
     [Google Scholar]
  11. ZhouH.J. WangL.Q. WangD.B. YuJ.B. ZhuY. XuQ.S. ZhengX.J. ZhanR.Y. Long noncoding RNA MALAT1 contributes to inflammatory response of microglia following spinal cord injury via the modulation of a miR-199b/IKKβ/NF-κB signaling pathway.Am. J. Physiol. Cell Physiol.20183151C52C6110.1152/ajpcell.00278.201729631367
     [Google Scholar]
  12. ZhengY. ZhangZ. LiX. WuL. LiuX. LiuL. ChenJ. WeiD. LINC01572 is a novel prognostic biomarker and therapeutic target in lung adenocarcinoma.Front. in Bioscience-Landmark2023281025710.31083/j.fbl281025737919058
     [Google Scholar]
  13. ZhangW. ZhaoY. JiaY. BaiY. Prognostic value of long noncoding RNA LINC00924 in lung adenocarcinoma and its regulatory effect on tumor progression.Histol. Histopathol.20233951864237358073
     [Google Scholar]
  14. KangJ. AbudurufuM. ZhangS. JiangW. LuoH. lncRNA VIM-AS1 acts as a prognostic biomarker and promotes apoptosis in lung adenocarcinoma.J. Cancer20231481417142610.7150/jca.8363937283796
     [Google Scholar]
  15. CaiH. ChenS. WuZ. WangF. TangS. LiD. WangD. GuoW. Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma.Aging (Albany NY)20231522130411305810.18632/aging.20521837980166
     [Google Scholar]
  16. WangS. ZhouL. JiN. SunC. SunL. SunJ. DuY. ZhangN. LiY. LiuW. LuW. Targeting ACYP1- mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression.Drug Resist. Updat.20236910097610.1016/j.drup.2023.10097637210811
     [Google Scholar]
  17. ChenB. DingX. WanA. QiX. LinX. WangH. MuW. WangG. ZhengJ. Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.Sci. Rep.20231311624410.1038/s41598‑023‑42171‑537758722
     [Google Scholar]
  18. ZhangZ. LiuS. GaoT. YangY. LiQ. ZhaoL. A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma.PeerJ202311e1583910.7717/peerj.1583937609436
     [Google Scholar]
  19. LiX. LeiJ. ShiY. PengZ. GongM. ShuX. Developing a riskscore model based on angiogenesis-related lncRNAs for colon adenocarcinoma prognostic prediction.Curr. Med. Chem.202431172449246610.2174/010929867327724323110807162037961859
     [Google Scholar]
  20. LiX. LiuH. WangF. YuanJ. GuanW. XuG. Prediction model for therapeutic responses in ovarian cancer patients using paclitaxel-resistant immune-related lncRNAs.Curr. Med. Chem.202431264213423110.2174/010929867328143823121715112938357948
     [Google Scholar]
  21. FuZ. LaiY. WangQ. LinF. FangJ. LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: a bioinformatics study.Endocr. Connect.2023131e23041810.1530/EC‑23‑041837991216
     [Google Scholar]
  22. GkirgkirisK. PapoutsiE. AthanasiouN. GκoufasS. SiemposI.I. Drug-overdose associated acute hypoxemic respiratory failure: A secondary analysis.Pneumon20243711810.18332/pne/176933
     [Google Scholar]
  23. LuR. LiY. XieyidaiA. YuT. FengY. Exploring the role of DKK1 in the occurrence of lung adenocarcinoma based on the analysis of bioinformatics.Zhongguo Fei Ai Za Zhi202326857959037752538
     [Google Scholar]
  24. LiuJ. LichtenbergT. HoadleyK.A. PoissonL.M. LazarA.J. CherniackA.D. KovatichA.J. BenzC.C. LevineD.A. LeeA.V. OmbergL. WolfD.M. ShriverC.D. ThorssonV. HuH. Caesar-JohnsonS.J. DemchokJ.A. FelauI. KasapiM. FergusonM.L. HutterC.M. SofiaH.J. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ.J. ChudamaniS. LiuJ. LollaL. NareshR. PihlT. SunQ. WanY. WuY. ChoJ. DeFreitasT. FrazerS. GehlenborgN. GetzG. HeimanD.I. KimJ. LawrenceM.S. LinP. MeierS. NobleM.S. SaksenaG. VoetD. ZhangH. BernardB. ChambweN. DhankaniV. KnijnenburgT. KramerR. LeinonenK. LiuY. MillerM. ReynoldsS. ShmulevichI. ThorssonV. ZhangW. AkbaniR. BroomB.M. HegdeA.M. JuZ. KanchiR.S. KorkutA. LiJ. LiangH. LingS. LiuW. LuY. MillsG.B. NgK-S. RaoA. RyanM. WangJ. WeinsteinJ.N. ZhangJ. AbeshouseA. ArmeniaJ. ChakravartyD. ChatilaW.K. de BruijnI. GaoJ. GrossB.E. HeinsZ.J. KundraR. LaK. LadanyiM. LunaA. NissanM.G. OchoaA. PhillipsS.M. ReznikE. Sanchez-VegaF. SanderC. SchultzN. SheridanR. SumerS.O. SunY. TaylorB.S. WangJ. ZhangH. AnurP. PetoM. SpellmanP. BenzC. StuartJ.M. WongC.K. YauC. HayesD.N. ParkerJ.S. WilkersonM.D. AllyA. BalasundaramM. BowlbyR. BrooksD. CarlsenR. ChuahE. DhallaN. HoltR. JonesS.J.M. KasaianK. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. MungallK. RobertsonA.G. SadeghiS. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. TseK. WongT. BergerA.C. BeroukhimR. CherniackA.D. CibulskisC. GabrielS.B. GaoG.F. HaG. MeyersonM. SchumacherS.E. ShihJ. KucherlapatiM.H. KucherlapatiR.S. BaylinS. CopeL. DanilovaL. BootwallaM.S. LaiP.H. MaglinteD.T. Van Den BergD.J. WeisenbergerD.J. AumanJ.T. BaluS. BodenheimerT. FanC. HoadleyK.A. HoyleA.P. JefferysS.R. JonesC.D. MengS. MieczkowskiP.A. MoseL.E. PerouA.H. PerouC.M. RoachJ. ShiY. SimonsJ.V. SkellyT. SolowayM.G. TanD. VeluvoluU. FanH. HinoueT. LairdP.W. ShenH. ZhouW. BellairM. ChangK. CovingtonK. CreightonC.J. DinhH. DoddapaneniH.V. DonehowerL.A. DrummondJ. GibbsR.A. GlennR. HaleW. HanY. HuJ. KorchinaV. LeeS. LewisL. LiW. LiuX. MorganM. MortonD. MuznyD. SantibanezJ. ShethM. ShinbroE. WangL. WangM. WheelerD.A. XiL. ZhaoF. HessJ. AppelbaumE.L. BaileyM. CordesM.G. DingL. FronickC.C. FultonL.A. FultonR.S. KandothC. MardisE.R. McLellanM.D. MillerC.A. SchmidtH.K. WilsonR.K. CrainD. CurleyE. GardnerJ. LauK. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. ShermanM. ThompsonE. YenaP. BowenJ. Gastier-FosterJ.M. GerkenM. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. CorcoranN. CostelloT. HovensC. CarvalhoA.L. de CarvalhoA.C. FregnaniJ.H. Longatto-FilhoA. ReisR.M. Scapulatempo-NetoC. SilveiraH.C.S. VidalD.O. BurnetteA. EschbacherJ. HermesB. NossA. SinghR. AndersonM.L. CastroP.D. IttmannM. HuntsmanD. KohlB. LeX. ThorpR. AndryC. DuffyE.R. LyadovV. PaklinaO. SetdikovaG. ShabuninA. TavobilovM. McPhersonC. WarnickR. BerkowitzR. CramerD. FeltmateC. HorowitzN. KibelA. MutoM. RautC.P. MalykhA. Barnholtz-SloanJ.S. BarrettW. DevineK. FulopJ. OstromQ.T. ShimmelK. WolinskyY. SloanA.E. De RoseA. GiulianteF. GoodmanM. KarlanB.Y. HagedornC.H. EckmanJ. HarrJ. MyersJ. TuckerK. ZachL.A. DeyarminB. HuH. KvecherL. LarsonC. MuralR.J. SomiariS. VichaA. ZelinkaT. BennettJ. IacoccaM. RabenoB. SwansonP. LatourM. LacombeL. TêtuB. BergeronA. McGrawM. StaugaitisS.M. ChabotJ. HibshooshH. SepulvedaA. SuT. WangT. PotapovaO. VoroninaO. DesjardinsL. MarianiO. Roman-RomanS. SastreX. SternM-H. ChengF. SignorettiS. BerchuckA. BignerD. LippE. MarksJ. McCallS. McLendonR. SecordA. SharpA. BeheraM. BratD.J. ChenA. DelmanK. ForceS. KhuriF. MaglioccaK. MaithelS. OlsonJ.J. OwonikokoT. PickensA. RamalingamS. ShinD.M. SicaG. Van MeirE.G. ZhangH. EijckenboomW. GillisA. KorpershoekE. LooijengaL. OosterhuisW. StoopH. van KesselK.E. ZwarthoffE.C. CalatozzoloC. CuppiniL. CuzzubboS. DiMecoF. FinocchiaroG. MatteiL. PerinA. PolloB. ChenC. HouckJ. LohavanichbutrP. HartmannA. StoehrC. StoehrR. TaubertH. WachS. WullichB. KyclerW. MurawaD. WiznerowiczM. ChungK. EdenfieldW.J. MartinJ. BaudinE. BubleyG. BuenoR. De RienzoA. RichardsW.G. KalkanisS. MikkelsenT. NoushmehrH. ScarpaceL. GirardN. AymerichM. CampoE. GinéE. GuillermoA.L. Van BangN. HanhP.T. PhuB.D. TangY. ColmanH. EvasonK. DottinoP.R. MartignettiJ.A. GabraH. JuhlH. AkeredoluT. StepaS. HoonD. AhnK. KangK.J. BeuschleinF. BreggiaA. BirrerM. BellD. BoradM. BryceA.H. CastleE. ChandanV. ChevilleJ. CoplandJ.A. FarnellM. FlotteT. GiamaN. HoT. KendrickM. KocherJ-P. KoppK. MoserC. NagorneyD. O’BrienD. O’NeillB.P. PatelT. PetersenG. QueF. RiveraM. RobertsL. SmallridgeR. SmyrkT. StantonM. ThompsonR.H. TorbensonM. YangJ.D. ZhangL. BrimoF. AjaniJ.A. Angulo GonzalezA.M. BehrensC. BondarukJ. BroaddusR. CzerniakB. EsmaeliB. FujimotoJ. GershenwaldJ. GuoC. LazarA.J. LogothetisC. Meric-BernstamF. MoranC. RamondettaL. RiceD. SoodA. TamboliP. ThompsonT. TroncosoP. TsaoA. WistubaI. CarterC. HayduL. HerseyP. JakrotV. KakavandH. KeffordR. LeeK. LongG. MannG. QuinnM. SawR. ScolyerR. ShannonK. SpillaneA. StretchJ. SynottM. ThompsonJ. WilmottJ. Al-AhmadieH. ChanT.A. GhosseinR. GopalanA. LevineD.A. ReuterV. SingerS. SinghB. TienN.V. BroudyT. MirsaidiC. NairP. DrwiegaP. MillerJ. SmithJ. ZarenH. ParkJ-W. HungN.P. KebebewE. LinehanW.M. MetwalliA.R. PacakK. PintoP.A. SchiffmanM. SchmidtL.S. VockeC.D. WentzensenN. WorrellR. YangH. MoncrieffM. GoparajuC. MelamedJ. PassH. BotnariucN. CaramanI. CernatM. ChemencedjiI. ClipcaA. DorucS. GorincioiG. MuraS. PirtacM. StanculI. TcaciucD. AlbertM. AlexopoulouI. ArnaoutA. BartlettJ. EngelJ. GilbertS. ParfittJ. SekhonH. ThomasG. RasslD.M. RintoulR.C. BifulcoC. TamakawaR. UrbaW. HaywardN. TimmersH. AntenucciA. FaccioloF. GraziG. MarinoM. MerolaR. de KrijgerR. Gimenez-RoqueploA-P. PichéA. ChevalierS. McKercherG. BirsoyK. BarnettG. BrewerC. FarverC. NaskaT. PennellN.A. RaymondD. SchileroC. SmolenskiK. WilliamsF. MorrisonC. BorgiaJ.A. LiptayM.J. PoolM. SederC.W. JunkerK. OmbergL. DinkinM. ManikhasG. AlvaroD. BragazziM.C. CardinaleV. CarpinoG. GaudioE. CheslaD. CottinghamS. DubinaM. MoiseenkoF. DhanasekaranR. BeckerK-F. JanssenK-P. Slotta-HuspeninaJ. Abdel-RahmanM.H. AzizD. BellS. CebullaC.M. DavisA. DuellR. ElderJ.B. HiltyJ. KumarB. LangJ. LehmanN.L. MandtR. NguyenP. PilarskiR. RaiK. SchoenfieldL. SenecalK. WakelyP. HansenP. LechanR. PowersJ. TischlerA. GrizzleW.E. SextonK.C. KastlA. HendersonJ. PortenS. WaldmannJ. FassnachtM. AsaS.L. SchadendorfD. CouceM. GraefenM. HulandH. SauterG. SchlommT. SimonR. TennstedtP. OlabodeO. NelsonM. BatheO. CarrollP.R. ChanJ.M. DisaiaP. GlennP. KelleyR.K. LandenC.N. PhillipsJ. PradosM. SimkoJ. Smith-McCuneK. VandenBergS. RogginK. FehrenbachA. KendlerA. SifriS. SteeleR. JimenoA. CareyF. ForgieI. MannelliM. CarneyM. HernandezB. CamposB. Herold-MendeC. JungkC. UnterbergA. von DeimlingA. BosslerA. GalbraithJ. JacobusL. KnudsonM. KnutsonT. MaD. MilhemM. SigmundR. GodwinA.K. MadanR. RosenthalH.G. AdebamowoC. AdebamowoS.N. BoussioutasA. BeerD. GiordanoT. Mes-MassonA-M. SaadF. BocklageT. LandrumL. MannelR. MooreK. MoxleyK. PostierR. WalkerJ. ZunaR. FeldmanM. ValdiviesoF. DhirR. LuketichJ. Mora PineroE.M. Quintero-AguiloM. CarlottiC.G.Jr Dos SantosJ.S. KempR. SankarankutyA. TirapelliD. CattoJ. AgnewK. SwisherE. CreaneyJ. RobinsonB. ShelleyC.S. GodwinE.M. KendallS. ShipmanC. BradfordC. CareyT. HaddadA. MoyerJ. PetersonL. PrinceM. RozekL. WolfG. BowmanR. FongK.M. YangI. KorstR. RathmellW.K. Fantacone-CampbellJ.L. HookeJ.A. KovatichA.J. ShriverC.D. DiPersioJ. DrakeB. GovindanR. HeathS. LeyT. Van TineB. WesterveltP. RubinM.A. LeeJ.I. AredesN.D. MariamidzeA. Cancer Genome Atlas Research Network An Integrated TCGA Pan-cancer Clinical data resource to drive high-quality survival outcome analytics.Cell20181732400416.e1110.1016/j.cell.2018.02.05229625055
     [Google Scholar]
  25. ChenB. GaoC. WangH. SunJ. HanZ. Molecular analysis of prognosis and immune infiltration of ovarian cancer based on Homeobox D genes.Comput. Math. Methods Med.2022202211610.1155/2022/326838636213580
     [Google Scholar]
  26. WangG. LiY. PanR. YinX. JiaC. SheY. HuangL. YangG. ChiH. TianG. XRCC1: A potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.Aging (Albany NY)202416187291010.18632/aging.20542638217545
     [Google Scholar]
  27. ChenT. ZhuC. WangX. PanY. LncRNA ELF3-AS1 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.Can. J. Gastroenterol. Hepatol.2021202111210.1155/2021/832348734336727
     [Google Scholar]
  28. GuoJ. FengS. LiuH. ChenZ. DingC. JinY. ChenX. LingY. ZengY. LongH. QiuH. TRIM6: An upregulated biomarker with prognostic significance and immune correlations in gliomas.Biomolecules2023139129810.3390/biom1309129837759698
     [Google Scholar]
  29. PanH. LiuQ. ZhangF. WangX. WangS. ShiX. High STK40 expression as an independent prognostic biomarker and correlated with immune infiltrates in low- grade gliomas.Int. J. Gen. Med.2021146389640010.2147/IJGM.S33582134675607
     [Google Scholar]
  30. TaoS. CuiD. ChengH. LiuX. JiangZ. ChenH. GaoY. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.BMC Cancer202424119410.1186/s12885‑024‑11943‑138347489
     [Google Scholar]
  31. XieH. WuZ. LiZ. HuangY. ZouJ. ZhouH. Significance of ZEB2 in the immune microenvironment of colon cancer.Front. Genet.20221399533310.3389/fgene.2022.99533336072677
     [Google Scholar]
  32. ZhangL. QianY. An epithelial–mesenchymal transition-related prognostic model for colorectal cancer based on weighted gene co-expression network analysis.J. Int. Med. Res.20225012P. 03000605221140683.10.1177/0300060522114068336510452
     [Google Scholar]
  33. HänzelmannS. CasteloR. GuinneyJ. GSVA: Gene set variation analysis for microarray and RNA-Seq data.BMC Bioinformatics2013141710.1186/1471‑2105‑14‑723323831
     [Google Scholar]
  34. BindeaG. MlecnikB. TosoliniM. KirilovskyA. WaldnerM. ObenaufA.C. AngellH. FredriksenT. LafontaineL. BergerA. BrunevalP. FridmanW.H. BeckerC. PagèsF. SpeicherM.R. TrajanoskiZ. GalonJ. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.Immunity201339478279510.1016/j.immuni.2013.10.00324138885
     [Google Scholar]
  35. ChenB. LuX. ZhouQ. ChenQ. ZhuS. LiG. LiuH. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.PLoS One2023188e029003110.1371/journal.pone.029003137582104
     [Google Scholar]
  36. YoshiharaK. ShahmoradgoliM. MartínezE. VegesnaR. KimH. Torres-GarciaW. TreviñoV. ShenH. LairdP.W. LevineD.A. CarterS.L. GetzG. Stemke-HaleK. MillsG.B. VerhaakR.G.W. Inferring tumour purity and stromal and immune cell admixture from expression data.Nat. Commun.201341261210.1038/ncomms361224113773
     [Google Scholar]
  37. HuangQ. HuangY. XuS. YuanX. LiuX. ChenZ. Association of asthma and lung cancer risk: A pool of cohort studies and Mendelian randomization analysis.Medicine (Baltimore)20241035e3506010.1097/MD.000000000003506038306564
     [Google Scholar]
  38. XiongL. WeiY. ZhouX. DaiP. CaiY. ZhouX. XuM. ZhaoJ. TangH. AGTR1 inhibits the progression of lung adenocarcinoma.Cancer Manag. Res.2021138535855010.2147/CMAR.S33554334803402
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673321029241015153958
Loading
LNX1-AS2 as a Key Prognostic and Immunotherapy Response Biomarker for Lung Adenocarcinoma
Curr. Med. Chem. 32, 7894 (2025); https://doi.org/10.2174/0109298673321029241015153958
/content/journals/cmc/10.2174/0109298673321029241015153958
/content/journals/cmc/10.2174/0109298673321029241015153958
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): biomarker; expression; immune infiltration; LNX1-AS2; Lung adenocarcinoma; prognosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test